{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:03:51Z","timestamp":1780959831954,"version":"3.54.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Celaid Therapeutics"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP222640019"],"award-info":[{"award-number":["JP222640019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP222640019"],"award-info":[{"award-number":["JP222640019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP222640019"],"award-info":[{"award-number":["JP222640019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP222640019"],"award-info":[{"award-number":["JP222640019"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48204-z","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:17:19Z","timestamp":1776352639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous administration of ex vivo expanded human umbilical cord blood-derived CD34\u207a\u2009cells in a preterm hypoxic-ischemic encephalopathy mouse model"],"prefix":"10.1038","volume":"16","author":[{"given":"Natsumu","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"48204_CR1","doi-asserted-by":"publisher","first-page":"1242936","DOI":"10.3389\/fnins.2023.1242936","volume":"17","author":"Y Mo","year":"2023","unstructured":"Mo, Y. et al. Early-stage effect of HIBD on neuro-motor function and organic composition of neurovascular units in neonatal rats. Front. Neurosci. 17, 1242936. https:\/\/doi.org\/10.3389\/fnins.2023.1242936 (2023).","journal-title":"Front. Neurosci."},{"key":"48204_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fneur.2014.00200","volume":"5","author":"J Li","year":"2014","unstructured":"Li, J., McDonald, C. A., Fahey, M. C., Jenkin, G. & Miller, S. L. Could cord blood cell therapy reduce preterm brain injury? Front. Neurol. 5, 200. https:\/\/doi.org\/10.3389\/fneur.2014.00200 (2014).","journal-title":"Front. Neurol."},{"key":"48204_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.22670","volume":"71","author":"L Bennet","year":"2012","unstructured":"Bennet, L. et al. Cell therapy for neonatal hypoxia-ischemia and cerebral palsy. Ann. Neurol. 71, 589\u2013600. https:\/\/doi.org\/10.1002\/ana.22670 (2012).","journal-title":"Ann. Neurol."},{"key":"48204_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clp.2008.07.012","volume":"35","author":"AJ Gunn","year":"2008","unstructured":"Gunn, A. J. & Bennet, L. Brain cooling for preterm infants. Clin. Perinatol. 35, 735\u2013748. https:\/\/doi.org\/10.1016\/j.clp.2008.07.012 (2008).","journal-title":"Clin. Perinatol."},{"key":"48204_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jpeds.2013.09.049","volume":"164","author":"MF de Almeida","year":"2014","unstructured":"de Almeida, M. F. et al. Hypothermia and early neonatal mortality in preterm infants. J. Pediatr. 164, 271\u2013275e271. https:\/\/doi.org\/10.1016\/j.jpeds.2013.09.049 (2014).","journal-title":"J. Pediatr."},{"key":"48204_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jnr.21857","volume":"87","author":"AA Hall","year":"2009","unstructured":"Hall, A. A. et al. Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death. J. Neurosci. Res. 87, 333\u2013341. https:\/\/doi.org\/10.1002\/jnr.21857 (2009).","journal-title":"J. Neurosci. Res."},{"key":"48204_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2014.03.030","volume":"1563","author":"LH Zhu","year":"2014","unstructured":"Zhu, L. H. et al. Improvement of human umbilical cord mesenchymal stem cell transplantation on glial cell and behavioral function in a neonatal model of periventricular white matter damage. Brain Res. 1563, 13\u201321. https:\/\/doi.org\/10.1016\/j.brainres.2014.03.030 (2014).","journal-title":"Brain Res."},{"key":"48204_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/STROKEAHA.112.679092","volume":"44","author":"SY Ahn","year":"2013","unstructured":"Ahn, S. Y. et al. Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage. Stroke 44, 497\u2013504. https:\/\/doi.org\/10.1161\/STROKEAHA.112.679092 (2013).","journal-title":"Stroke"},{"key":"48204_CR9","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000346683","volume":"35","author":"T Yawno","year":"2013","unstructured":"Yawno, T. et al. Human amnion epithelial cells reduce fetal brain injury in response to intrauterine inflammation. Dev. Neurosci. 35, 272\u2013282. https:\/\/doi.org\/10.1159\/000346683 (2013).","journal-title":"Dev. Neurosci."},{"key":"48204_CR10","doi-asserted-by":"publisher","first-page":"151598","DOI":"10.1016\/j.semperi.2022.151598","volume":"46","author":"G Vinukonda","year":"2022","unstructured":"Vinukonda, G. & La Gamma, E. F. Emerging therapies for brain recovery after IVH in neonates: cord blood derived mesenchymal stem cells (MSC) and unrestricted somatic stem cells (USSC). Semin Perinatol. 46, 151598. https:\/\/doi.org\/10.1016\/j.semperi.2022.151598 (2022).","journal-title":"Semin Perinatol."},{"key":"48204_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CM Cotten","year":"2014","unstructured":"Cotten, C. M. et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 164, 973\u2013979. https:\/\/doi.org\/10.1016\/j.jpeds.2013.11.036 (2014). .e971.","journal-title":"J. Pediatr."},{"key":"48204_CR12","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1038\/s41598-020-61311-9","volume":"10","author":"M Tsuji","year":"2020","unstructured":"Tsuji, M. et al. Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety. Sci. Rep. 10, 4603. https:\/\/doi.org\/10.1038\/s41598-020-61311-9 (2020).","journal-title":"Sci. Rep."},{"key":"48204_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/leu.2008.323","volume":"23","author":"V Rocha","year":"2009","unstructured":"Rocha, V. et al. Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia. Leukemia 23, 545\u2013556. https:\/\/doi.org\/10.1038\/leu.2008.323 (2009).","journal-title":"Leukemia"},{"key":"48204_CR14","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1182\/blood.v97.10.3075","volume":"97","author":"M Majka","year":"2001","unstructured":"Majka, M. et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine\/paracrine manner. Blood 97, 3075\u20133085. https:\/\/doi.org\/10.1182\/blood.v97.10.3075 (2001).","journal-title":"Blood"},{"key":"48204_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev.med.54.101601.152334","volume":"56","author":"JA Shizuru","year":"2005","unstructured":"Shizuru, J. A., Negrin, R. S. & Weissman, I. L. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56, 509\u2013538. https:\/\/doi.org\/10.1146\/annurev.med.54.101601.152334 (2005).","journal-title":"Annu. Rev. Med."},{"key":"48204_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2217\/rme.09.74","volume":"5","author":"PR Baraniak","year":"2010","unstructured":"Baraniak, P. R. & McDevitt, T. C. Stem cell paracrine actions and tissue regeneration. Regen Med. 5, 121\u2013143. https:\/\/doi.org\/10.2217\/rme.09.74 (2010).","journal-title":"Regen Med."},{"key":"48204_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.hoc.2010.11.006","volume":"25","author":"A Czechowicz","year":"2011","unstructured":"Czechowicz, A. & Weissman, I. L. Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement. Hematol. Oncol. Clin. North. Am. 25, 75\u201387. https:\/\/doi.org\/10.1016\/j.hoc.2010.11.006 (2011).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"48204_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-065X.1997.tb00971.x","volume":"157","author":"HL Aguila","year":"1997","unstructured":"Aguila, H. L. et al. From stem cells to lymphocytes: biology and transplantation. Immunol. Rev. 157, 13\u201340. https:\/\/doi.org\/10.1111\/j.1600-065X.1997.tb00971.x (1997).","journal-title":"Immunol. Rev."},{"key":"48204_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000454830","volume":"38","author":"M Ohshima","year":"2016","unstructured":"Ohshima, M. et al. Evaluations of intravenous administration of CD34\u2009+\u2009human umbilical cord blood cells in a mouse model of neonatal hypoxic-ischemic encephalopathy. Dev. Neurosci. 38, 331\u2013341. https:\/\/doi.org\/10.1159\/000454830 (2016).","journal-title":"Dev. Neurosci."},{"key":"48204_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.braindev.2018.08.007","volume":"41","author":"Y Yu","year":"2019","unstructured":"Yu, Y. et al. Effects of human umbilical cord blood CD34(+) cell transplantation in neonatal hypoxic-ischemia rat model. Brain Dev. 41, 173\u2013181. https:\/\/doi.org\/10.1016\/j.braindev.2018.08.007 (2019).","journal-title":"Brain Dev."},{"key":"48204_CR21","doi-asserted-by":"publisher","unstructured":"Paton, M. C. B. et al. Updates on neonatal cell and novel therapeutics: proceedings of the Second Neonatal Cell Therapies Symposium (2024) Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-025-03856-x (2025).","DOI":"10.1038\/s41390-025-03856-x"},{"key":"48204_CR22","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.1191536","volume":"329","author":"AE Boitano","year":"2010","unstructured":"Boitano, A. E. et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329, 1345\u20131348. https:\/\/doi.org\/10.1126\/science.1191536 (2010).","journal-title":"Science"},{"key":"48204_CR23","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1256337","volume":"345","author":"I Fares","year":"2014","unstructured":"Fares, I. et al. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345, 1509\u20131512. https:\/\/doi.org\/10.1126\/science.1256337 (2014).","journal-title":"Science"},{"key":"48204_CR24","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1016\/S2352-3026(19)30202-9","volume":"7","author":"S Cohen","year":"2020","unstructured":"Cohen, S. et al. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1\u20132 safety and feasibility study. Lancet Haematol. 7, e134\u2013e145. https:\/\/doi.org\/10.1016\/S2352-3026(19)30202-9 (2020).","journal-title":"Lancet Haematol."},{"key":"48204_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.stem.2015.10.004","volume":"18","author":"JE Wagner","year":"2016","unstructured":"Wagner, J. E. et al. Phase I\/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft. Cell. Stem Cell. 18, 144\u2013155. https:\/\/doi.org\/10.1016\/j.stem.2015.10.004 (2016).","journal-title":"Cell. Stem Cell."},{"key":"48204_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41586-019-1244-x","volume":"571","author":"AC Wilkinson","year":"2019","unstructured":"Wilkinson, A. C. et al. Long-term ex vivo haematopoietic-stem-cell expansion allows nonconditioned transplantation. Nature 571, 117\u2013121. https:\/\/doi.org\/10.1038\/s41586-019-1244-x (2019).","journal-title":"Nature"},{"key":"48204_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-023-05739-9","volume":"615","author":"M Sakurai","year":"2023","unstructured":"Sakurai, M. et al. Chemically defined cytokine-free expansion of human haematopoietic stem cells. Nature 615, 127\u2013133. https:\/\/doi.org\/10.1038\/s41586-023-05739-9 (2023).","journal-title":"Nature"},{"key":"48204_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13287-024-03830-0","volume":"15","author":"TR Penny","year":"2024","unstructured":"Penny, T. R., Jenkin, G., Miller, S. L. & McDonald, C. A. Umbilical cord blood derived cell expansion: a potential neuroprotective therapy. Stem Cell. Res. Ther. 15, 234. https:\/\/doi.org\/10.1186\/s13287-024-03830-0 (2024).","journal-title":"Stem Cell. Res. Ther."},{"key":"48204_CR29","doi-asserted-by":"publisher","first-page":"129e121","DOI":"10.1016\/j.jtct.2022.11.007","volume":"29","author":"T Saiyin","year":"2023","unstructured":"Saiyin, T. et al. Clinical outcomes of umbilical cord blood transplantation using ex vivo expansion: a systematic review and meta-analysis of controlled studies. Transpl. Cell. Ther. 29, 129e121\u2013129e129. https:\/\/doi.org\/10.1016\/j.jtct.2022.11.007 (2023).","journal-title":"Transpl. Cell. Ther."},{"key":"48204_CR30","doi-asserted-by":"publisher","unstructured":"Chua, S. J. et al. The effect of umbilical cord blood cells on outcomes after experimental traumatic spinal cord injury. Spine (Phila. PA) 35, 1520\u20131526. (1976). https:\/\/doi.org\/10.1097\/BRS.0b013e3181c3e963 (2010).","DOI":"10.1097\/BRS.0b013e3181c3e963"},{"key":"48204_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s12015-014-9496-1","volume":"10","author":"J Whiteley","year":"2014","unstructured":"Whiteley, J. et al. An expanded population of CD34\u2009+\u2009cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model. Stem Cell. Rev. Rep. 10, 338\u2013350. https:\/\/doi.org\/10.1007\/s12015-014-9496-1 (2014).","journal-title":"Stem Cell. Rev. Rep."},{"key":"48204_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.neuroscience.2014.01.018","volume":"263","author":"M Tsuji","year":"2014","unstructured":"Tsuji, M. et al. Effects of intravenous administration of umbilical cord blood CD34(+) cells in a mouse model of neonatal stroke. Neuroscience 263, 148\u2013158. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.01.018 (2014).","journal-title":"Neuroscience"},{"key":"48204_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fneur.2018.00133","volume":"9","author":"E Tanaka","year":"2018","unstructured":"Tanaka, E. et al. Dose-dependent effect of intravenous administration of human umbilical cord-derived mesenchymal stem cells in neonatal stroke mice. Front. Neurol. 9, 133. https:\/\/doi.org\/10.3389\/fneur.2018.00133 (2018).","journal-title":"Front. Neurol."},{"key":"48204_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1582-4934.2008.00671.x","volume":"14","author":"T Yasuhara","year":"2010","unstructured":"Yasuhara, T. et al. Mannitol facilitates neurotrophic factor up-regulation and behavioural recovery in neonatal hypoxic-ischaemic rats with human umbilical cord blood grafts. J. Cell. Mol. Med. 14, 914\u2013921. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00671.x (2010).","journal-title":"J. Cell. Mol. Med."},{"key":"48204_CR35","doi-asserted-by":"publisher","first-page":"e51253","DOI":"10.1371\/journal.pone.0051253","volume":"8","author":"V Donega","year":"2013","unstructured":"Donega, V. et al. Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement. PLoS One 8, e51253. https:\/\/doi.org\/10.1371\/journal.pone.0051253 (2013).","journal-title":"PLoS One"},{"key":"48204_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jns.2007.05.007","volume":"265","author":"T Ben-Hur","year":"2008","unstructured":"Ben-Hur, T. Immunomodulation by neural stem cells. J. Neurol. Sci. 265, 102\u2013104. https:\/\/doi.org\/10.1016\/j.jns.2007.05.007 (2008).","journal-title":"J. Neurol. Sci."},{"key":"48204_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2016.06.017","volume":"283","author":"J Li","year":"2016","unstructured":"Li, J. et al. Preterm white matter brain injury is prevented by early administration of umbilical cord blood cells. Exp. Neurol. 283, 179\u2013187. https:\/\/doi.org\/10.1016\/j.expneurol.2016.06.017 (2016).","journal-title":"Exp. Neurol."},{"key":"48204_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/stcltm\/szad006","volume":"12","author":"E Purcell","year":"2023","unstructured":"Purcell, E. et al. Factors influencing the efficacy of umbilical cord blood-derived cell therapy for perinatal brain injury. Stem Cells Transl. Med. 12, 125\u2013139. https:\/\/doi.org\/10.1093\/stcltm\/szad006 (2023).","journal-title":"Stem Cells Transl Med."},{"key":"48204_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/ped.14604","volume":"63","author":"Y Sato","year":"2021","unstructured":"Sato, Y. & Tsuji, M. Diverse actions of cord blood cell therapy for hypoxic-ischemic encephalopathy. Pediatr. Int. 63, 497\u2013503. https:\/\/doi.org\/10.1111\/ped.14604 (2021).","journal-title":"Pediatr. Int."},{"key":"48204_CR40","doi-asserted-by":"publisher","first-page":"113430","DOI":"10.1016\/j.intimp.2024.113430","volume":"143","author":"L Qi","year":"2024","unstructured":"Qi, L. et al. Advances in mesenchymal stem cell-centered stem cell therapy in the treatment of hypoxic-ischemic injury. Int. Immunopharmacol. 143, 113430. https:\/\/doi.org\/10.1016\/j.intimp.2024.113430 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"48204_CR41","doi-asserted-by":"publisher","first-page":"63142","DOI":"10.3390\/ijms22063142","volume":"22","author":"I Serrenho","year":"2021","unstructured":"Serrenho, I. et al. Stem cell therapy for neonatal hypoxic-ischemic encephalopathy: a systematic review of preclinical studies. Int. J. Mol. Sci. 22, 63142. https:\/\/doi.org\/10.3390\/ijms22063142 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"48204_CR42","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1007\/s12035-022-02967-4","volume":"59","author":"A Asgari Taei","year":"2022","unstructured":"Asgari Taei, A., Khodabakhsh, P., Nasoohi, S., Farahmandfar, M. & Dargahi, L. Paracrine effects of mesenchymal stem cells in ischemic stroke: opportunities and challenges. Mol. Neurobiol. 59, 6281\u20136306. https:\/\/doi.org\/10.1007\/s12035-022-02967-4 (2022).","journal-title":"Mol. Neurobiol."},{"key":"48204_CR43","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1182\/blood.v97.3.799","volume":"97","author":"C Voermans","year":"2001","unstructured":"Voermans, C. et al. In vitro migratory capacity of CD34\u2009+\u2009cells is related to hematopoietic recovery after autologous stem cell transplantation. Blood 97, 799\u2013804. https:\/\/doi.org\/10.1182\/blood.v97.3.799 (2001).","journal-title":"Blood"},{"key":"48204_CR44","doi-asserted-by":"publisher","first-page":"30892","DOI":"10.18632\/oncotarget.8810","volume":"7","author":"Y Kong","year":"2016","unstructured":"Kong, Y. et al. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants. Oncotarget 7, 30892\u201330906. https:\/\/doi.org\/10.18632\/oncotarget.8810 (2016).","journal-title":"Oncotarget"},{"key":"48204_CR45","doi-asserted-by":"publisher","first-page":"e20194","DOI":"10.1371\/journal.pone.0020194","volume":"6","author":"M Geissler","year":"2011","unstructured":"Geissler, M., Dinse, H. R., Neuhoff, S., Kreikemeier, K. & Meier, C. Human umbilical cord blood cells restore brain damage induced changes in rat somatosensory cortex. PLoS One. 6, e20194. https:\/\/doi.org\/10.1371\/journal.pone.0020194 (2011).","journal-title":"PLoS One"},{"key":"48204_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00441-012-1401-0","volume":"348","author":"K Rosenkranz","year":"2012","unstructured":"Rosenkranz, K. et al. Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats. Cell. Tissue Res. 348, 429\u2013438. https:\/\/doi.org\/10.1007\/s00441-012-1401-0 (2012).","journal-title":"Cell. Tissue Res."},{"key":"48204_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/scd.2009.0049","volume":"19","author":"PM Pimentel-Coelho","year":"2010","unstructured":"Pimentel-Coelho, P. M. et al. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells Dev. 19, 351\u2013358. https:\/\/doi.org\/10.1089\/scd.2009.0049 (2010).","journal-title":"Stem Cells Dev."},{"key":"48204_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.brainres.2012.05.066","volume":"1487","author":"B Wasielewski","year":"2012","unstructured":"Wasielewski, B., Jensen, A., Roth-H\u00e4rer, A., Dermietzel, R. & Meier, C. Neuroglial activation and Cx43 expression are reduced upon transplantation of human umbilical cord blood cells after perinatal hypoxic-ischemic injury. Brain Res. 1487, 39\u201353. https:\/\/doi.org\/10.1016\/j.brainres.2012.05.066 (2012).","journal-title":"Brain Res."},{"key":"48204_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.aanat.2012.09.003","volume":"195","author":"K Rosenkranz","year":"2013","unstructured":"Rosenkranz, K., Tenbusch, M., May, C., Marcus, K. & Meier, C. Changes in interleukin-1 alpha serum levels after transplantation of umbilical cord blood cells in a model of perinatal hypoxic-ischemic brain damage. Ann. Anat. 195, 122\u2013127. https:\/\/doi.org\/10.1016\/j.aanat.2012.09.003 (2013).","journal-title":"Ann. Anat."},{"key":"48204_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1750-3639.2005.tb00525.x","volume":"15","author":"RL Haynes","year":"2005","unstructured":"Haynes, R. L. et al. Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol. 15, 225\u2013233. https:\/\/doi.org\/10.1111\/j.1750-3639.2005.tb00525.x (2005).","journal-title":"Brain Pathol."},{"key":"48204_CR51","doi-asserted-by":"publisher","unstructured":"Zhou, L. et al. Feasibility and safety of autologous cord blood derived cell administration in extremely preterm infants: a single-centre, open-label, single-arm, phase I trial (CORD-SaFe study). EBioMedicine 111, 105492. (2025). https:\/\/doi.org\/10.1016\/j.ebiom.2024.105492","DOI":"10.1016\/j.ebiom.2024.105492"},{"key":"48204_CR52","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","volume":"111","author":"C Schmidt-Lucke","year":"2005","unstructured":"Schmidt-Lucke, C. et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111, 2981\u20132987. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.504340 (2005).","journal-title":"Circulation"},{"key":"48204_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/STROKEAHA.107.489401","volume":"39","author":"HK Yip","year":"2008","unstructured":"Yip, H. K. et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 39, 69\u201374. https:\/\/doi.org\/10.1161\/STROKEAHA.107.489401 (2008).","journal-title":"Stroke"},{"key":"48204_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bjh.15902","volume":"186","author":"A Leonard","year":"2019","unstructured":"Leonard, A. et al. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery. Br. J. Haematol. 186, 286\u2013299. https:\/\/doi.org\/10.1111\/bjh.15902 (2019).","journal-title":"Br. J. Haematol."},{"key":"48204_CR55","doi-asserted-by":"publisher","unstructured":"Zarrabi, M. et al. The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial. BMC Neurol. 22 https:\/\/doi.org\/10.1186\/s12883-022-02636-y (2022).","DOI":"10.1186\/s12883-022-02636-y"},{"key":"48204_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/mrdd.10007","volume":"8","author":"H Hagberg","year":"2002","unstructured":"Hagberg, H., Peebles, D. & Mallard, C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment. Retard. Dev. Disabil. Res. Rev. 8, 30\u201338. https:\/\/doi.org\/10.1002\/mrdd.10007 (2002).","journal-title":"Ment Retard. Dev. Disabil. Res. Rev."},{"key":"48204_CR57","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ana.410090206","volume":"9","author":"JE Rice","year":"1981","unstructured":"Rice, J. E., Vannucci, R. C. & Brierley, J. B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9, 131\u2013141. https:\/\/doi.org\/10.1002\/ana.410090206 (1981).","journal-title":"Ann. Neurol."},{"key":"48204_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.expneurol.2011.11.025","volume":"233","author":"M Ohshima","year":"2012","unstructured":"Ohshima, M., Tsuji, M., Taguchi, A., Kasahara, Y. & Ikeda, T. Cerebral blood flow during reperfusion predicts later brain damage in a mouse and a rat model of neonatal hypoxic-ischemic encephalopathy. Exp. Neurol. 233, 481\u2013489. https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.025 (2012).","journal-title":"Exp. Neurol."},{"key":"48204_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00004647-200103000-00002","volume":"21","author":"AK Dunn","year":"2001","unstructured":"Dunn, A. K., Bolay, H., Moskowitz, M. A. & Boas, D. A. Dynamic imaging of cerebral blood flow using laser speckle. J. Cereb. Blood Flow. Metab. 21, 195\u2013201. https:\/\/doi.org\/10.1097\/00004647-200103000-00002 (2001).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"48204_CR60","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/BF02345307","volume":"40","author":"KR Forrester","year":"2002","unstructured":"Forrester, K. R., Stewart, C., Tulip, J., Leonard, C. & Bray, R. C. Comparison of laser speckle and laser Doppler perfusion imaging: measurement in human skin and rabbit articular tissue. Med. Biol. Eng. Comput. 40, 687\u2013697. https:\/\/doi.org\/10.1007\/BF02345307 (2002).","journal-title":"Med. Biol. Eng. Comput."},{"key":"48204_CR61","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1172\/JCI20622","volume":"114","author":"A Taguchi","year":"2004","unstructured":"Taguchi, A. et al. Administration of CD34\u2009+\u2009cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J. Clin. Invest. 114, 330\u2013338. https:\/\/doi.org\/10.1172\/JCI20622 (2004).","journal-title":"J. Clin. Invest."},{"key":"48204_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2174\/157016112799959369","volume":"10","author":"M Uemura","year":"2012","unstructured":"Uemura, M., Kasahara, Y., Nagatsuka, K. & Taguchi, A. Cell-based therapy to promote angiogenesis in the brain following ischemic damage. Curr. Vasc Pharmacol. 10, 285\u2013288. https:\/\/doi.org\/10.2174\/157016112799959369 (2012).","journal-title":"Curr. Vasc Pharmacol."},{"key":"48204_CR63","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.braindev.2014.06.010","volume":"37","author":"M Ohshima","year":"2015","unstructured":"Ohshima, M. et al. Intraperitoneal and intravenous deliveries are not comparable in terms of drug efficacy and cell distribution in neonatal mice with hypoxia-ischemia. Brain Dev. 37, 376\u2013386. https:\/\/doi.org\/10.1016\/j.braindev.2014.06.010 (2015).","journal-title":"Brain Dev."},{"key":"48204_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.expneurol.2004.01.011","volume":"189","author":"M Tsuji","year":"2004","unstructured":"Tsuji, M., Wilson, M. A., Lange, M. S. & Johnston, M. V. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp. Neurol. 189, 58\u201365. https:\/\/doi.org\/10.1016\/j.expneurol.2004.01.011 (2004).","journal-title":"Exp. Neurol."},{"key":"48204_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.expneurol.2011.10.004","volume":"233","author":"M Tsuji","year":"2012","unstructured":"Tsuji, M., Taguchi, A., Ohshima, M., Kasahara, Y. & Ikeda, T. Progesterone and allopregnanolone exacerbate hypoxic-ischemic brain injury in immature rats. Exp. Neurol. 233, 214\u2013220. https:\/\/doi.org\/10.1016\/j.expneurol.2011.10.004 (2012).","journal-title":"Exp. Neurol."},{"key":"48204_CR66","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.expneurol.2013.04.015","volume":"247","author":"M Tsuji","year":"2013","unstructured":"Tsuji, M. et al. A novel reproducible model of neonatal stroke in mice: comparison with a hypoxia-ischemia model. Exp. Neurol. 247, 218\u2013225. https:\/\/doi.org\/10.1016\/j.expneurol.2013.04.015 (2013).","journal-title":"Exp. Neurol."},{"key":"48204_CR67","doi-asserted-by":"publisher","first-page":"39377","DOI":"10.1038\/srep39377","volume":"6","author":"M Ohshima","year":"2016","unstructured":"Ohshima, M. et al. Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity. Sci. Rep. 6, 39377. https:\/\/doi.org\/10.1038\/srep39377 (2016).","journal-title":"Sci. Rep."},{"key":"48204_CR68","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3389\/fneur.2018.00397","volume":"9","author":"Y Ogawa","year":"2018","unstructured":"Ogawa, Y., Tsuji, M., Tanaka, E., Miyazato, M. & Hino, J. Bone morphogenetic protein (BMP)-3b gene depletion causes high mortality in a mouse model of neonatal hypoxic-ischemic encephalopathy. Front. Neurol. 9, 397. https:\/\/doi.org\/10.3389\/fneur.2018.00397 (2018).","journal-title":"Front. Neurol."},{"key":"48204_CR69","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/ana.23543","volume":"71","author":"CT van Velthoven","year":"2012","unstructured":"van Velthoven, C. T. et al. Mesenchymal stem cells restore cortical rewiring after neonatal ischemia in mice. Ann. Neurol. 71, 785\u2013796. https:\/\/doi.org\/10.1002\/ana.23543 (2012).","journal-title":"Ann. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48204-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48204-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:55:43Z","timestamp":1780959343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48204-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48204"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48204-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was financially supported by Celaid Therapeutics, which also provided the cells used in the experiments. The funder had no influence on the study design, data collection and analysis, decision to publish, or manuscript preparation. Additional support was provided by JSPS KAKENHI (Grant Number JP222640019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17736"}}